MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$7,634,000
EPS
-$2.99
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Revenue
0
0
0
0
Research and development
3,621,000
3,474,000
2,205,000
3,298,000
General and administrative
3,561,000
3,954,000
2,708,000
3,623,000
Total operating expenses
7,182,000
7,428,000
4,913,000
6,921,000
Interest income
-
26,250*
-
-
Other (expense) income, net
-19,000
-
-
-
Interest expense, related party
433,000
358,250*
-
-
Interest (expense) income
-
-
-212,000
-110,000
Change in fair value of warrants
-
0*
-
-
Foreign exchange gain
-
1,000
2,000
-12,000
Total other expenses
-452,000
-331,000
-210,000
-122,000
Net loss and comprehensive loss
-7,634,000
-7,759,000
-5,123,000
-7,043,000
Unrealized loss on available-for-sale securities
-
-
-
0
Total comprehensive loss
-
-
-
-7,043,000
Basic EPS
-2.99
-3.033
-2.01
-2.76
Diluted EPS
-2.99
-3.033
-2.01
-2.76
Basic Average Shares
2,552,429
2,558,267
2,552,429
2,552,429
Diluted Average Shares
2,552,429
2,558,267
2,552,429
2,552,429
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss and
comprehensive loss
-$7,634,000
(-37.72%↓ Y/Y)
Total operating
expenses
$7,182,000
(31.51%↑ Y/Y)
Total other expenses
-$452,000
(-451.22%↓ Y/Y)
Research and development
$3,621,000
(53.17%↑ Y/Y)
General and
administrative
$3,561,000
(14.98%↑ Y/Y)
Interest expense,
related party
$433,000
Other (expense)
income, net
-$19,000
Buy us a coffee
Aptose Biosciences Inc. (APTOF)
Aptose Biosciences Inc. (APTOF)